Eversept Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.2M Buy
+120,785
New +$16.9M 0.75% 33
2025
Q4
Sell
-105,087
Closed -$14M 118
2025
Q3
$14M Buy
105,087
+86,467
+464% +$10.5M 0.97% 26
2025
Q2
$2.32M Buy
18,620
+168
+0.9% +$21.4K 0.21% 51
2025
Q1
$2.35M Sell
18,452
-35,614
-66% -$5.48M 0.24% 39
2024
Q4
$7.78M Sell
54,066
-109,527
-67% -$15.7M 0.69% 30
2024
Q3
$24.3M Sell
163,593
-30,698
-16% -$4.4M 1.67% 17
2024
Q2
$24.5M Buy
194,291
+186,054
+2,259% +$29.2M 1.68% 15
2024
Q1
$1.51M Sell
8,237
-1,747
-17% -$333K 0.1% 66
2023
Q4
$1.8M Sell
9,984
-6,169
-38% -$960K 0.16% 52
2023
Q3
$2.57M Sell
16,153
-49,914
-76% -$8.16M 0.22% 58
2023
Q2
$9.35M Buy
66,067
+60,411
+1,068% +$9.69M 0.78% 30
2023
Q1
$952K Sell
5,656
-51,348
-90% -$9.16M 0.07% 59
2022
Q4
$9.65M Buy
57,004
+53,363
+1,466% +$9.68M 0.85% 26
2022
Q3
$681K Sell
3,641
-2,052
-36% -$433K 0.06% 60
2022
Q2
$925K Sell
5,693
-30,828
-84% -$4.88M 0.07% 66
2022
Q1
$6.87M Buy
36,521
+31,937
+697% +$6.07M 0.53% 43
2021
Q4
$1.21M Buy
4,584
+182
+4% +$49K 0.08% 86
2021
Q3
$1.27M Buy
4,402
+710
+19% +$182K 0.09% 90
2021
Q2
$737K Buy
3,692
+2,264
+159% +$439K 0.05% 84
2021
Q1
$278K Buy
+1,428
New +$293K 0.02% 84

Other funds holding RGEN

Eversept Partners's RGEN Position: Q1 2026 in Review

Eversept Partners opened a new position in Repligen (RGEN) in Q1 2026: 120,785 shares worth $14.2M. The stake represents 0.75% of the portfolio and ranks #33 among its holdings. This is a return to the name: Eversept Partners previously reported a position in RGEN as recently as Q3 2025.

Eversept Partners first reported a position in RGEN in Q1 2021 and has held it in 20 quarters since. The position peaked at $24.5M in Q2 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Eversept Partners held 120,785 shares of Repligen worth $14.2M as of Q1 2026.
  • Repligen was a new Eversept Partners position in Q1 2026.
  • Repligen made up 0.75% of Eversept Partners's portfolio in Q1 2026, its #33 holding.
  • Eversept Partners first reported a position in Repligen in Q1 2021 and has held it in 20 quarters since.
  • Eversept Partners's Repligen position peaked at $24.5M in Q2 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Eversept Partners's 13F filing for Q1 2026, filed 15 May 2026.